Anita Dushyanth
Stock Analyst at Berenberg
(2.58)
# 1,991
Out of 5,182 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $24.12 | -17.08% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $1.98 | +556.57% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.06 | +113,107.55% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $25.41 | +266.00% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $24.12
Upside: -17.08%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $1.98
Upside: +556.57%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.06
Upside: +113,107.55%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $25.41
Upside: +266.00%